Bellevue Group Ag Axsome Therapeutics, Inc. Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 367,181 shares of AXSM stock, worth $31.9 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

367,181

Previous 516,533 28.91%

Holding current value

$31.9 Million

Previous $41.6 Million 20.66%

% of portfolio

0.56%

Previous 0.7%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $11.8 Million - $14.3 Million	-149,352 Reduced 28.91%	367,181 $33 Million
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $11.1 Million - $13.6 Million	-168,943 Reduced 24.65%	516,533 $41.6 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $3.48 Million - $4.89 Million	50,104 Added 7.89%	685,476 $54.7 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $223,076 - $324,824	3,885 Added 0.62%	635,372 $50.6 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $3.96 Million - $4.7 Million	57,124 Added 9.95%	631,487 $44.1 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $7.77 Million - $12 Million	133,013 Added 30.14%	574,363 $41.3 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $273,965 - $351,900	4,692 Added 1.07%	441,350 $27.2 Million
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $2.39 Million - $4.77 Million	-59,866 Reduced 12.06%	436,658 $33.7 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $11.6 Million - $22.4 Million	-320,617 Reduced 39.24%	496,524 $22.2 Million
Q2 2022 Aug 11, 2022	BUY	$21.74 - $46.75 $2.12 Million - $4.57 Million	97,659 Added 13.57%	817,141 $31.3 Million
Q1 2022 May 13, 2022	BUY	$23.7 - $41.39 $1.6 Million - $2.8 Million	67,545 Added 10.36%	719,482 $29.8 Million
Q4 2021 Feb 10, 2022	SELL	$30.7 - $43.36 $3.1 Million - $4.38 Million	-101,008 Reduced 13.42%	651,937 $24.6 Million
Q3 2021 Nov 12, 2021	BUY	$19.91 - $68.26 $7.98 Million - $27.4 Million	400,924 Added 113.89%	752,945 $24.8 Million
Q2 2021 Aug 12, 2021	BUY	$50.63 - $73.5 $17.8 Million - $25.9 Million	352,021 New	352,021 $23.7 Million

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Axsome Therapeutics, Inc. Transaction History